KHC
11
2
EXR
42
5
WM
53
2
RF
44
10
AIV
39
6
TGNA
48
5
SNA
56
3
APA
30
5
AAL
56
5
ADT
12
2
GOOG
77
14
HRB
40
3
HBI
53
4
MAR
57
3
EXPE
83
8
TXN
29
4
IPG
43
3
ZBH
69
15
LEN
21
3
NEE
39
9
KHC
11
2
EXR
42
5
WM
53
2
RF
44
10
AIV
39
6
TGNA
48
5
SNA
56
3
APA
30
5
AAL
56
5
ADT
12
2
GOOG
77
14
HRB
40
3
HBI
53
4
MAR
57
3
EXPE
83
8
TXN
29
4
IPG
43
3
ZBH
69
15
LEN
21
3
NEE
39
9
Financhill
Back

Cellectis SA Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison

Sell
34

CLLS
Cellectis SA

Last Price:
$1.58
Seasonality Move:
-10.57%
Sell
26

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
$3.93
Seasonality Move:
-9.68%
Sell
34
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.61. The Score for CLLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals PLC [BDRX] share price is $3.90. The Score for BDRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals PLC's stock price today?

  • The Biodexa Pharmaceuticals PLC share price today is $3.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 31.65 Sell
Chaikin Money Flow: 71561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.74 - 2.04) Sell
Bollinger Bands (100): (1.83 - 2.23) Sell

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 36.56 Sell
Chaikin Money Flow: -21346 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.85 - 5.31) Sell
Bollinger Bands (100): (4.16 - 12.28) Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.72 Sell
20-day SMA: 1.89 Sell
50-day SMA: 1.88 Sell
200-day SMA: 2.26 Sell
8-day EMA: 1.71 Sell
20-day EMA: 1.82 Sell
50-day EMA: 1.9 Sell
200-day EMA: 2.17 Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.16 Sell
20-day SMA: 4.77 Sell
50-day SMA: 5.23 Sell
200-day SMA: 16.83 Sell
8-day EMA: 4.19 Sell
20-day EMA: 4.56 Sell
50-day EMA: 5.73 Sell
200-day EMA: 217.03 Sell

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biodexa Pharmaceuticals PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):